Cleared Traditional

SENSITESTER (K871167) - FDA 510(k) Clearance

Class I Neurology device.

K871167 · Dexin Pty. , Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1987
Decision
8d
Days
Class 1
Risk

K871167 is an FDA 510(k) clearance for the SENSITESTER. Classified as Pinwheel (product code GWY), Class I - General Controls.

Submitted by Dexin Pty. , Ltd. (Western Australia, AU). The FDA issued a Cleared decision on April 1, 1987 after a review of 8 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1750 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dexin Pty. , Ltd. devices

Submission Details

510(k) Number K871167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 1987
Decision Date April 01, 1987
Days to Decision 8 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
140d faster than avg
Panel avg: 148d · This submission: 8d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GWY Pinwheel
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 882.1750
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.